The predictive power of artificial intelligence on mediastinal lymphnode metastasis
Yohei Kawaguchi1, Yosuke Matsuura2, Yasuto Kondo1
1Department of Thoracic Surgical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Artificial intelligence shows high specificity for predicting lung adenocarcinoma mediastinal lymph node metastasis. While promising, its low sensitivity requires further development before clinical application.
Area of Science:
- Oncology
- Radiology
- Artificial Intelligence
Background:
- Mediastinal lymph node metastasis is crucial in lung adenocarcinoma staging.
- Accurate preoperative prediction aids treatment planning.
- Current methods have limitations in predicting metastasis.
Purpose of the Study:
- To develop an artificial intelligence (AI)-based preoperative predictive model for mediastinal lymph node metastasis in lung adenocarcinoma.
- To evaluate the AI model's performance against traditional methods.
Main Methods:
- A cohort of 301 patients with resected lung adenocarcinoma (clinical stage N0-1) was analyzed.
- Patients were divided into training (n=201) and validation (n=100) sets.
- An automatic machine learning platform was used to create the AI model.
- Multivariate analysis identified predictive factors, including maximum standardized uptake value (SUVmax).
Main Results:
- The AI model achieved 84% accuracy and 98% specificity.
- SUVmax showed 61% accuracy and 57% specificity.
- The AI model's sensitivity was notably low at 12%.
Conclusions:
- AI demonstrates high specificity in predicting mediastinal lymph node metastasis in lung adenocarcinoma.
- The AI model shows potential to enhance existing diagnostic tools.
- Further research is needed to improve sensitivity for clinical readiness.
More Related Videos
07:15Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
